Q2FY23 Financial Summary and Strategic Highlights slide image

Q2FY23 Financial Summary and Strategic Highlights

Diabetes Neuroscience Medical Surgical Cardiovascular Broad, robust pipeline to accelerate growth Visibility into multiple catalysts in fast-growth medical device end-markets; 180 approvals in the last 12 months Launched n Just launching/ expect in next few quarters Investing heavily in mid- to long-range pipeline DiamondTemp TM Micra TM AV and RF Ablation System Harmony VR Transcatheter Transcatheter PV Pacing System VenaSeal™ Closure System Abre TM Self- Expanding Stent EvolutTM FX TAVR System DCB AV LINQ™ II Access Onyx Frontier™ Indication Aurora Extravascular ICD (EV-ICD) Symplicity TN Renal Denervation TM Pulsed Field Ablation 80 99 IntrepidⓇ Mitral and Tricuspid Valve Replacement Half Moon Mitral Repair Illumisite Platform Signia T Powered Stapler TM TriStaple EEATM Circular Stapler Gl Genius ProdiGITM Sonicision™M 7mm Nellcor™ OxySoft Pulse Ox Sensor Touch Surgery T Enterprise Hugo TM RAS System Signia™ Circular RespArray™ Vital Sync™ Monitor Endoflip T 300 EXTANEL Vanta T Recharge the Intellis™ Free SCS platform DTMTM SCS on Solitaire TM X SenSightTM Percept™ Directional PC Deep Brain Stimulator Leads InterStim™ X SCS primary cell treatment device for DPN NuVent™ Next-gen NIMⓇ balloon Nerve Monitoring System Pipeline™ Vantage with Shield Technology TM Flow Diverter Guardian Connect™ Standalone Sensor InPen Smart Diabetes Pen MiniMed™ 770G Bluetooth Enabled Extended Infusion Set 12 Investor Meetings | November 2022 *MiniMed™ 780G is available OUS and is currently under review with the FDA Mini MedTM 780G Advanced Hybrid Closed-Loop System* Guardian TM 4 Sensor (Zeus) CGM Sensor Inceptiv SCS using Closed-Loop Intrasaccular Deep Brain Spine Enabling (ECAPS) Device Ⓡ nutrino *KLUE Exclusives: Personalization & Meal Handling Simplera TM CGM Sensor (Synergy) Medtronic Hemorrhagic Stroke Closed-Loop Stimulator Next-Gen Technologies
View entire presentation